Skip to Main Content

Author Details

Andrew J G Simpson
University of Hull
1980
292
59
PMIDPaper TitleJournal TitlePublished Year
36629074Telerehabilitation for patients who have been hospitalised with covid-19: a qualitative study.Disabil Rehabil2024
36891071NICE asthma guidelines: time to re-evaluate the diagnostic value of exercise challenge testing?ERJ Open Res2023
36915803Group-based pulmonary telerehabilitation is feasible, safe, beneficial and well-received in patients who have been hospitalised with COVID-19.ERJ Open Res2023
36862716Short-term heat acclimation protocols for an aging population: Systematic review.PLoS One2023
36395344Effectiveness of short-term isothermic-heat acclimation (4 days) on physical performance in moderately trained males.PLoS One2022
26029206Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant.Front Immunol2015
26244168Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.Oncoscience2015
26528202Auditory scene analysis and sonified visual images. Does consonance negatively impact on object formation when using complex sonified stimuli?Front Psychol2015
24478375Selective adaptation to "oddball" sounds by the human auditory system.J Neurosci2014
25693300Visual objects in the auditory system in sensory substitution: how much information do we need?Multisens Res2014
25193853Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.Oncotarget2014
24797829CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.J Neurooncol2014
24699824Vaccines and early breast cancer.Cell Cycle2014
23085758Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.Oncogene2013
25593980Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast.Oncoscience2013
24777967NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches.Cancer Immunol Res2013
24340093Centrosomal localisation of the cancer/testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells.PLoS One2013
24040323Syncopation and the score.PLoS One2013
24009759Tuning of human modulation filters is carrier-frequency dependent.PLoS One2013
23625514Effects of CT-Xp gene knock down in melanoma cell lines.Oncotarget2013
23536749The dynamic range paradox: a central auditory model of intensity change detection.PLoS One2013
22156296Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.Genome Res2012
23390371MAGE-A3 is highly expressed in a subset of colorectal cancer patients.Cancer Immun2012
23133577Differential evolution of MAGE genes based on expression pattern and selection pressure.PLoS One2012
21493686Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual.Nucleic Acids Res2011
21766840Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA.ACS Chem Biol2011
21876767MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression.PLoS One2011
21691740Insights on PRAME and osteosarcoma by means of gene expression profiling.J Orthop Sci2011
21494657Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.PLoS One2011
21437249Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers.PLoS One2011
20055453Rational design of indoleamine 2,3-dioxygenase inhibitors.J Med Chem2010
21108794Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing.Genome Biol2010
20862285Frequent MAGE mutations in human melanoma.PLoS One2010
20642837Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.Breast Cancer Res2010
20029419Whole-genome cancer analysis as an approach to deeper understanding of tumour biology.Br J Cancer2010
18838390CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens.Nucleic Acids Res2009
19956396Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes.Transl Oncol2009
19651608CT-X antigen expression in human breast cancer.Proc Natl Acad Sci U S A2009
19805368Bioinformatics construction of the human cell surfaceome.Proc Natl Acad Sci U S A2009
19540335Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis.Genomics2009
19181860Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line.Proc Natl Acad Sci U S A2009
19171422SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis.Cancer Lett2009
19125018Sequence-based advances in the definition of cancer-associated gene mutations.Curr Opin Oncol2009
19296537Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.Int J Cancer2009
19211183Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma.Exp Hematol2009
17899192Identification and expression analysis of novel LAGE-1 alleles with single nucleotide polymorphisms in cancer patients.J Cancer Res Clin Oncol2008
19088187Genome-wide analysis of cancer/testis gene expression.Proc Natl Acad Sci U S A2008
18834847The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.Acta Trop2008
18519755ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.Clin Cancer Res2008
18426187Cancer-testis (CT) antigen expression in medulloblastoma.Cancer Immun2008
  • 1 - 50 of 292

Recommended Authors

Magdalena Zarowiecki
European Bioinformatics Institute
Career Start Year 2007
Number of shared co-authors 2
Paul H Davis
University of Nebraska at Omaha
Career Start Year 2003
Number of shared co-authors 1
Neil Hall
Earlham Institute
Career Start Year 2000
Number of shared co-authors 4
Lee Murphy
Edinburgh Clinical Research Facility, University of Edinburgh
Career Start Year 1998
Number of shared co-authors 6
Matthew Berriman
Wellcome Sanger Institute
Career Start Year 1998
Number of shared co-authors 7
Arnab Pain
King Abdullah University of Science and Technology
Career Start Year 1997
Number of shared co-authors 11
Robert A Holt
BC Cancer Research Institute
Career Start Year 1996
Number of shared co-authors 11
Sandra W Clifton
Garvan Institute of Medical Research
Career Start Year 1994
Number of shared co-authors 8
Jes??s Vald??s
Center for Research and Advanced Studies of the IPN, National Polytechnic Institute
Career Start Year 1990
Number of shared co-authors 0
Philip J R Day
University of Cape Town
Career Start Year 1988
Number of shared co-authors 5
Conor R Caffrey
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1987
Number of shared co-authors 0
Alasdair Ivens
University of Washington School of Medicine
Career Start Year 1987
Number of shared co-authors 1
Satyajit Ray
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1986
Number of shared co-authors 0
Bruce W Birren
Broad Institute of MIT and Harvard
Career Start Year 1983
Number of shared co-authors 17
Wesley C Van Voorhis
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Career Start Year 1982
Number of shared co-authors 0
Hans-Michael M??ller
Heidelberg University Biochemistry Center
Career Start Year 1982
Number of shared co-authors 1
Peter J Myler
University of Guelph
Career Start Year 1981
Number of shared co-authors 2
Vishvanath Nene
International Livestock Research Institute (ILRI)
Career Start Year 1980
Number of shared co-authors 6
Brian Seed
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 2
Jorge Zamora
Universidade de Santiago de Compostela
Career Start Year 1979
Number of shared co-authors 2
Hugh Dawkins
The University of Notre Dame Australia
Career Start Year 1979
Number of shared co-authors 0
Claire M Fraser
Institute for Genome Sciences, University of Maryland School of Medicine
Career Start Year 1979
Number of shared co-authors 15
Thomas E Fehniger
Biomedical Center, Lund University
Career Start Year 1979
Number of shared co-authors 0
Gregory A Buck
Virginia Commonwealth University.
Career Start Year 1978
Number of shared co-authors 2
Dyann F Wirth
The Broad Institute
Career Start Year 1977
Number of shared co-authors 2
Ross L Coppel
Nursing and Health SciencesMonash UniversityClaytonVictoriaAustralia.
Career Start Year 1975
Number of shared co-authors 1
Barend Mons
Leiden University Medical Center
Career Start Year 1973
Number of shared co-authors 4
James H McKerrow
Sandler Center for Drug Discovery, University of California San Francisco
Career Start Year 1970
Number of shared co-authors 0
Young-Ki Paik
College of Life Sciences and Biotechnology, Yonsei University
Career Start Year 1962
Number of shared co-authors 4
Leroy Hood
Center for Phenomic Health, The Buck Institute for Research on Aging
Career Start Year 1961
Number of shared co-authors 14

Collaborators

Otavia L Caballero
Ludwig Institute for Cancer Research Ltd.
Co-authored papers 57
Anamaria A Camargo
Hospital Sirio-Libanes
Co-authored papers 37
Emmanuel Dias-Neto
A.C. Camargo Cancer Center
Co-authored papers 34
Lloyd J Old
Ludwig Institute for Cancer Research
Co-authored papers 27
Sandro J de Souza
Universidade Federal do Rio Grande do Norte
Co-authored papers 25
Robert L Strausberg
Ludwig Institute for Cancer Research
Co-authored papers 23
Yao-Tseng Chen
From Population Health Services (Chen)
Co-authored papers 17
Wilson A Silva
Ribeirao Preto Medical School - University of Sao Paulo
Co-authored papers 15
Marco A Zago
Center for Cell-Based Therapy (CTC)
Co-authored papers 14
Dirce Maria Carraro
AC Camargo Cancer Center
Co-authored papers 10
Suely Kazue Nagahashi Marie
Co-authored papers 9
Sueli Mieko Oba-Shinjo
Co-authored papers 8
Qi Zhao
University of Science and Technology Liaoning
Co-authored papers 8
Ana Tereza Ribeiro de Vasconcelos
The National Laboratory for Scientific Computing (LNCC)
Co-authored papers 8
Pedro A F Galante
Hospital Sirio Libanes
Co-authored papers 8
Raphael B Parmigiani
Sirio-Libanes Hospital
Co-authored papers 8
Anna C M Salim
Instituto Rene Rachou
Co-authored papers 7
Gregory J Riggins
Co-authored papers 7
Jorge Estefano Santana de Souza
Instituto Metropole Digital, Universidade Federal do Rio Grande do Norte
Co-authored papers 6
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Jo??o C Setubal
Chemistry Institute, Universidade de Sao Paulo - USP
Co-authored papers 5
Luiz F L Reis
Universidade Federal de Santa Maria
Co-authored papers 5
Nasser K Altorki
New York-Presbyterian Hospital
Co-authored papers 5
Diana N Nunes
A.C. Camargo Cancer Center
Co-authored papers 5
Alan Mackay
Co-authored papers 5
Samuel Levy
Bluestar Genomics Inc.
Co-authored papers 5
Luiz Gonzaga Paula de Almeida
Center for Implant Dentistry, University of Florida
Co-authored papers 4
Daniel G Pinheiro
Faculdade de Ciencias Agrarias e Veterinarias, Universidade Estadual Paulista (UNESP)
Co-authored papers 4
Winston Hide
Harvard Medical School
Co-authored papers 4
Dana Busam
J. Craig Venter Institute
Co-authored papers 3
Release 1.2